뇌종양 진단 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2023-2031년)
Brain Cancer Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
상품코드:1402884
리서치사:Transparency Market Research
발행일:2023년 11월
페이지 정보:영문 180 Pages
라이선스 & 가격 (부가세 별도)
한글목차
뇌종양 진단 시장 - 보고서의 범위
세계 뇌종양 진단 시장에 대한 TMR의 보고서는 과거와 현재의 성장 동향과 2023년부터 2031년까지의 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻을 수 있는 기회를 조사했습니다. 이 보고서는 2023년을 기준 연도 및 2031년을 예측 연도로 간주하여 2017년부터 2031년까지의 세계 뇌종양 진단 수익을 제공합니다. 이 보고서는 또한 2023년부터 2031년까지 세계 뇌종양 진단 시장의 복합 연간 성장률(CAGR%)을 제공합니다.
이 보고서는 광범위한 조사를 통해 작성되었습니다. KOL(Key Opinion Leader), 업계 리더 및 제조업체를 인터뷰하는 1차 조사 활동의 대부분을 분석가들이 수행했으며, 2차 조사에는 뇌종양 진단 시장을 이해하기 위해 주요 업체의 제품 문헌, 연례 보고서, 보도 자료 및 관련 문서 참조가 포함되었습니다.
시장 현황
2023년 시장 가치
15억 달러
2031년 시장 가치
25억 달러
CAGR
5.9%
이 보고서는 세계 뇌종양 진단 시장의 경쟁 환경을 자세히 조사했습니다. 세계 뇌종양 진단 시장에서 활동하는 주요 기업이 식별되고 각 기업은 다양한 속성 측면에서 프로파일링됩니다. 기업 프로파일, 재무 상태, 최근 동향 및 SWOT는 이 보고서에 소개된 세계 뇌종양 진단 시장 기업의 속성입니다.
목차
제1장 서문
제2장 전제조건과 조사 방법
제3장 주요 요약 : 세계 시장
제4장 시장 개요
서론
개요
시장 역학
세계 시장 분석과 예측, 2023-2031년
제5장 주요 인사이트
뇌종양 역학
뇌종양 영상 진단 및 치료의 현재 동향
암 진단 기술의 발전
COVID-19의 영향 분석
제6장 세계 시장 분석과 예측 : 진단 방법별
서론과 정의
주요 조사 결과/발전
시장 매출 예측 : 진단 방법별, 2023-2031
이미징 기술
자기공명영상(MRI)
컴퓨터 단층촬영(CT) 스캔
PET 스캔 또는 PET-CT 스캔
(SPECT) 스캔
조직 샘플링/생검
분자진단
기타
시장의 매력 분석 : 진단 방법별
제7장 세계 시장 분석과 예측 : 뇌종양 유형별
서론과 정의
주요 조사 결과/발전
시장 매출 예측 : 뇌종양 유형별, 2023-2031
신경교종
수막종
하수체 종양
기타
시장의 매력 분석 : 뇌종양 유형별
제8장 세계 시장 분석과 예측 : 최종사용자별
서론과 정의
주요 조사 결과/발전
시장 매출 예측 : 최종사용자별, 2023-2031
병원
진단 실험실
암병원/센터
시장의 매력 분석 : 최종사용자별
제9장 세계 시장 분석과 예측 : 지역별
주요 조사 결과
시장 매출 예측 : 지역별
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
시장의 매력 분석 : 지역별
제10장 북미 시장 분석과 예측
제11장 유럽 시장 분석과 예측
제12장 아시아태평양 시장 분석과 예측
제13장 라틴아메리카 시장 분석과 예측
제14장 중동 및 아프리카 시장 분석과 예측
제15장 경쟁 구도
시장 기업--경쟁 매트릭스(기업 Tier 및 규모별)
기업별 시장 점유율 분석(2021)
기업 개요
GE Healthcare
Siemens Healthineers
Philips Healthcare
Thermo Fisher Scientific
Roche Diagnostics
Abbott Laboratories
Illumina, Inc.
Hologic, Inc.
Agilent Technologies
Bio-Rad Laboratories
LSH
영문 목차
영문목차
Brain Cancer Diagnostics Market - Scope of Report
TMR's report on the global brain cancer diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global brain cancer diagnostics market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global brain cancer diagnostics market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the brain cancer diagnostics market.
Market Snapshot
Market Value in 2023
US$ 1.5 Bn
Market Value in 2031
US$ 2.5 Bn
CAGR
5.9%
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global brain cancer diagnostics market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global brain cancer diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global brain cancer diagnostics market.
The report delves into the competitive landscape of the global brain cancer diagnostics market. Key players operating in the global brain cancer diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global brain cancer diagnostics market profiled in this report.
Key Questions Answered in Global brain cancer diagnostics Market Report:
What is the sales/revenue generated by brain cancer diagnostics across all regions during the forecast period?
What are the opportunities in the global brain cancer diagnostics market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2031?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Brain Cancer Diagnostics Market - Research Objectives and Research Approach
The comprehensive report on the global brain cancer diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global brain cancer diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global brain cancer diagnostics market.
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Brain Cancer Diagnostics Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Brain Cancer Diagnostics Market Analysis and Forecasts, 2023-2031
5. Key Insights
5.1. Brain Tumor Epidemiology
5.2. Current Trends in Diagnostic and Therapeutic Imaging of Brain Tumors
5.3. Technological advancements in cancer diagnostics
5.4. COVID-19 Impact Analysis
6. Global Brain Cancer Diagnostics Market Analysis and Forecasts, by Diagnostic Technique
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Diagnostic Technique, 2023-2031
6.3.1. Imaging Techniques
6.3.1.1. Magnetic Resonance Imaging (MRI)
6.3.1.2. Computed Tomography (CT) Scan
6.3.1.3. PET Scan or PET-CT Scan
6.3.1.4. (SPECT) Scan
6.3.2. Tissue Sampling/Biopsy
6.3.3. Molecular Diagnostics
6.3.4. Others
6.4. Market Attractiveness Analysis, by Diagnostic Technique
7. Global Brain Cancer Diagnostics Market Analysis and Forecasts, by Brain Cancer Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Brain Cancer Type, 2023-2031
7.3.1. Gliomas
7.3.2. Meningiomas
7.3.3. Pituitary Tumors
7.3.4. Others
7.4. Market Attractiveness Analysis, by Brain Cancer Type
8. Global Brain Cancer Diagnostics Market Analysis and Forecasts, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2023-2031
8.3.1. Hospitals
8.3.2. Diagnostic Laboratories
8.3.3. Cancer Hospitals/Centers
8.4. Market Attractiveness Analysis, by End-user
9. Global Brain Cancer Diagnostics Market Analysis and Forecasts, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Brain Cancer Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Diagnostic Technique, 2023-2031
10.2.1. Imaging Techniques
10.2.1.1. Magnetic Resonance Imaging (MRI)
10.2.1.2. Computed Tomography (CT) Scan
10.2.1.3. PET Scan or PET-CT Scan
10.2.1.4. (SPECT) Scan
10.2.2. Tissue Sampling/Biopsy
10.2.3. Molecular Diagnostics
10.2.4. Others
10.3. Market Value Forecast, by Brain Cancer Type, 2023-2031
10.3.1. Gliomas
10.3.2. Meningiomas
10.3.3. Pituitary Tumors
10.3.4. Others
10.4. Market Value Forecast, by End-user, 2023-2031
10.4.1. Hospitals
10.4.2. Diagnostic Laboratories
10.4.3. Cancer Hospitals/Centers
10.5. Market Value Forecast, by Country, 2023-2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Diagnostic Technique
10.6.2. By Brain Cancer Type
10.6.3. By End-user
10.6.4. By Country
11. Europe Brain Cancer Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Diagnostic Technique, 2023-2031
11.2.1. Imaging Techniques
11.2.1.1. Magnetic Resonance Imaging (MRI)
11.2.1.2. Computed Tomography (CT) Scan
11.2.1.3. PET Scan or PET-CT Scan
11.2.1.4. (SPECT) Scan
11.2.2. Tissue Sampling/Biopsy
11.2.3. Molecular Diagnostics
11.2.4. Others
11.3. Market Value Forecast, by Brain Cancer Type, 2023-2031
11.3.1. Gliomas
11.3.2. Meningiomas
11.3.3. Pituitary Tumors
11.3.4. Others
11.4. Market Value Forecast, by End-user, 2023-2031
11.4.1. Hospitals
11.4.2. Diagnostic Laboratories
11.4.3. Cancer Hospitals/Centers
11.5. Market Value Forecast, by Country/Sub-region, 2023-2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Diagnostic Technique
11.6.2. By Brain Cancer Type
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Brain Cancer Diagnostics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Diagnostic Technique, 2023-2031
12.2.1. Imaging Techniques
12.2.1.1. Magnetic Resonance Imaging (MRI)
12.2.1.2. Computed Tomography (CT) Scan
12.2.1.3. PET Scan or PET-CT Scan
12.2.1.4. (SPECT) Scan
12.2.2. Tissue Sampling/Biopsy
12.2.3. Molecular Diagnostics
12.2.4. Others
12.3. Market Value Forecast, by Brain Cancer Type, 2023-2031
12.3.1. Gliomas
12.3.2. Meningiomas
12.3.3. Pituitary Tumors
12.3.4. Others
12.4. Market Value Forecast, by End-user, 2023-2031
12.4.1. Hospitals
12.4.2. Diagnostic Laboratories
12.4.3. Cancer Hospitals/Centers
12.5. Market Value Forecast, by Country/Sub-region, 2023-2031
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Diagnostic Technique
12.6.2. By Brain Cancer Type
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Brain Cancer Diagnostics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Diagnostic Technique, 2023-2031
13.2.1. Imaging Techniques
13.2.1.1. Magnetic Resonance Imaging (MRI)
13.2.1.2. Computed Tomography (CT) Scan
13.2.1.3. PET Scan or PET-CT Scan
13.2.1.4. (SPECT) Scan
13.2.2. Tissue Sampling/Biopsy
13.2.3. Molecular Diagnostics
13.2.4. Others
13.3. Market Value Forecast, by Brain Cancer Type, 2023-2031
13.3.1. Gliomas
13.3.2. Meningiomas
13.3.3. Pituitary Tumors
13.3.4. Others
13.4. Market Value Forecast, by End-user, 2023-2031
13.4.1. Hospitals
13.4.2. Diagnostic Laboratories
13.4.3. Cancer Hospitals/Centers
13.5. Market Value Forecast, by Country/Sub-region, 2023-2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Diagnostic Technique
13.6.2. By Brain Cancer Type
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Brain Cancer Diagnostics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Diagnostic Technique, 2023-2031
14.2.1. Imaging Techniques
14.2.1.1. Magnetic Resonance Imaging (MRI)
14.2.1.2. Computed Tomography (CT) Scan
14.2.1.3. PET Scan or PET-CT Scan
14.2.1.4. (SPECT) Scan
14.2.2. Tissue Sampling/Biopsy
14.2.3. Molecular Diagnostics
14.2.4. Others
14.3. Market Value Forecast, by Brain Cancer Type, 2023-2031
14.3.1. Gliomas
14.3.2. Meningiomas
14.3.3. Pituitary Tumors
14.3.4. Others
14.4. Market Value Forecast, by End-user, 2023-2031
14.4.1. Hospitals
14.4.2. Diagnostic Laboratories
14.4.3. Cancer Hospitals/Centers
14.5. Market Value Forecast, by Country/Sub-region, 2023-2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Diagnostic Technique
14.6.2. By Brain Cancer Type
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of companies)
